PENTAX Medical Appoints Dr. Hudson Garrett Jr. as Global Chief Clinical Officer

MONTVALE, N.J., May 25, 2016 /PRNewswire/ -- PENTAX Medical Corp. (PENTAX Medical), a healthcare industry leader in endoscopic imaging, announced today that Dr. Hudson Garrett JR. joined the organization as Global Chief Clinical Offer. In this role, he is responsible for building the Global Clinical Affairs program by working with clinical partners and providers to create, advance, and translate evidence-based clinical practices that will benefit patients worldwide, across the continuum of care.

Dr. Garrett previously served as the Vice President of Clinical Affairs at PDI Inc., a provider of products, resources, and training to prevent healthcare associated infections. In addition, he serves as the Industry Liaison for the Association for the Healthcare Environment, a Personal Membership Group of the American Hospital Association.

"The healthcare industry is evolving rapidly and is in a state of learning and adapting," said Dr. Garrett. "The entire industry needs a sustainable focus on hygiene, infection prevention and control intervention, evidence-based clinical education, clinical research, and patient education and partnership. I am pleased to join PENTAX Medical because of its organizational commitment and partnership with healthcare providers and clinical partners to improve the patient experience, reduce costs and variations in clinical care, and improve clinical outcomes and population health. PENTAX Medical is uniquely positioning itself as a global leader in device hygiene and infection prevention and control."

Dr. Garrett has been published in Infection Control Today, Managing Infection Control, Provider, The Assisted Living Journal, The American Journal of Long Term Care, American Journal of Critical Care, and in several Mosby Saunders medical textbooks. He currently serves as an Associate Editor for the Journal of the Association of Vascular Access, the OSAP newsletter, and the Journal of Infusion Nursing.

Notably, Dr. Garrett received a Presidential Citation from the Society of Critical Care Medicine in 2011 recognizing his advancement of critical care nursing and infection prevention. He also chaired the task force that developed the first infection prevention and control board certification for post-acute care medical and nursing professionals at the National Association of Directors of Nursing Administration for Infection Prevention and Control in Post-Acute Care Setting. He was also honored as a "Who's Who in Infection Prevention and Control" by Infection Control Today Magazine in 2013.

"We are thrilled to have Dr. Garrett on board to build our thought leadership in device hygiene and infection prevention," David Woods, Global Chief Marketing Officer. "His breadth of experience and depth of knowledge, along with his passion for educating others and improving the quality of lives for patients, make him a valuable addition to the PENTAX team. Dr. Garrett embodies our mission of improving the standard of patient care and quality of healthcare delivery."

About PENTAX Medical

PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs. For more information, please visit: www.pentaxmedical.com.

SOURCE PENTAX Medical